• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素肠道-大脑信号在肥胖治疗中的作用。

Hormonal Gut-Brain Signaling for the Treatment of Obesity.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.

出版信息

Int J Mol Sci. 2023 Feb 8;24(4):3384. doi: 10.3390/ijms24043384.

DOI:10.3390/ijms24043384
PMID:36834794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9959457/
Abstract

The brain, particularly the hypothalamus and brainstem, monitors and integrates circulating metabolic signals, including gut hormones. Gut-brain communication is also mediated by the vagus nerve, which transmits various gut-derived signals. Recent advances in our understanding of molecular gut-brain communication promote the development of next-generation anti-obesity medications that can safely achieve substantial and lasting weight loss comparable to metabolic surgery. Herein, we comprehensively review the current knowledge about the central regulation of energy homeostasis, gut hormones involved in the regulation of food intake, and clinical data on how these hormones have been applied to the development of anti-obesity drugs. Insight into and understanding of the gut-brain axis may provide new therapeutic perspectives for the treatment of obesity and diabetes.

摘要

大脑,特别是下丘脑和脑干,监测和整合循环代谢信号,包括肠道激素。肠道-大脑通讯也通过迷走神经介导,迷走神经传递各种源自肠道的信号。我们对分子肠道-大脑通讯的理解的最新进展促进了下一代抗肥胖药物的开发,这些药物可以安全地实现与代谢手术相当的大量和持久的体重减轻。在此,我们全面回顾了关于能量平衡的中枢调节、参与调节食物摄入的肠道激素以及这些激素在开发抗肥胖药物方面的临床数据的现有知识。对肠道-大脑轴的深入了解和理解可能为肥胖和糖尿病的治疗提供新的治疗视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1696/9959457/dba16b07074d/ijms-24-03384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1696/9959457/c82a6ae7ff97/ijms-24-03384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1696/9959457/dba16b07074d/ijms-24-03384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1696/9959457/c82a6ae7ff97/ijms-24-03384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1696/9959457/dba16b07074d/ijms-24-03384-g002.jpg

相似文献

1
Hormonal Gut-Brain Signaling for the Treatment of Obesity.激素肠道-大脑信号在肥胖治疗中的作用。
Int J Mol Sci. 2023 Feb 8;24(4):3384. doi: 10.3390/ijms24043384.
2
Obesity and appetite control.肥胖与食欲控制
Exp Diabetes Res. 2012;2012:824305. doi: 10.1155/2012/824305. Epub 2012 Aug 1.
3
The gut-brain axis in obesity.肥胖中的肠-脑轴
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):559-71. doi: 10.1016/j.bpg.2014.07.003. Epub 2014 Jul 11.
4
Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.代谢手术与肠道激素——肥胖症肠-体液调节综述
Physiol Behav. 2009 Jul 14;97(5):620-31. doi: 10.1016/j.physbeh.2009.03.012. Epub 2009 Mar 20.
5
Hormonal interactions between gut and brain.肠道与大脑之间的激素相互作用。
Discov Med. 2010 Dec;10(55):543-52.
6
Obesity, gut hormones, and bariatric surgery.肥胖、肠道激素与减肥手术
World J Surg. 2009 Oct;33(10):1983-8. doi: 10.1007/s00268-009-0080-9.
7
Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?超重和肥胖个体肠道及脂肪组织激素的改变:原因还是结果?
Int J Obes (Lond). 2016 Apr;40(4):622-32. doi: 10.1038/ijo.2015.220. Epub 2015 Oct 26.
8
The role of gut hormones in appetite regulation (review).肠道激素在食欲调节中的作用(综述)
Acta Physiol Hung. 2014 Dec;101(4):395-407. doi: 10.1556/APhysiol.101.2014.4.1.
9
Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.减肥手术后肠道-脑轴的神经激素变化及潜在神经内分泌机制
Int J Mol Sci. 2022 Mar 19;23(6):3339. doi: 10.3390/ijms23063339.
10
The role of gut hormones and the hypothalamus in appetite regulation.肠道激素和下丘脑在食欲调节中的作用。
Endocr J. 2010;57(5):359-72. doi: 10.1507/endocrj.k10e-077. Epub 2010 Apr 14.

引用本文的文献

1
Vagal Oxytocin Receptors as Molecular Targets in Gut-Brain Signaling: Implications for Appetite, Satiety, Obesity, and Esophageal Motility-A Narrative Review.迷走神经催产素受体作为肠-脑信号传导中的分子靶点:对食欲、饱腹感、肥胖和食管动力的影响——一篇叙述性综述
Int J Mol Sci. 2025 Aug 13;26(16):7812. doi: 10.3390/ijms26167812.
2
Obesity: assessment and treatment across the care continuum.肥胖症:整个照护连续过程中的评估与治疗
Ann Med. 2025 Dec;57(1):2521433. doi: 10.1080/07853890.2025.2521433. Epub 2025 Jun 26.
3
Tirzepatide: a novel therapeutic approach for Alzheimer's disease.

本文引用的文献

1
Whole grain benefit: synergistic effect of oat phenolic compounds and β-glucan on hyperlipidemia gut microbiota in high-fat-diet mice.全谷物益处:燕麦酚类化合物和β-葡聚糖对高脂饮食小鼠高脂血症肠道微生物群的协同作用。
Food Funct. 2022 Dec 13;13(24):12686-12696. doi: 10.1039/d2fo01746f.
2
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.替尔泊肽,一种双重 GIP/GLP-1 受体激动剂,用于治疗 2 型糖尿病,在血糖控制和体重减轻方面具有无与伦比的疗效。
Cardiovasc Diabetol. 2022 Sep 1;21(1):169. doi: 10.1186/s12933-022-01604-7.
3
替尔泊肽:一种治疗阿尔茨海默病的新方法。
Metab Brain Dis. 2025 Jun 11;40(5):221. doi: 10.1007/s11011-025-01649-z.
4
Smoking, Obesity, and Post-Cessation Weight Gain: Neurobiological Intersection and Treatment Recommendations.吸烟、肥胖与戒烟后体重增加:神经生物学交叉点及治疗建议
J Multidiscip Healthc. 2025 May 24;18:2889-2900. doi: 10.2147/JMDH.S509971. eCollection 2025.
5
Gut-Brain Hormone Analogues and Metabolic Magic Wand.肠脑激素类似物与代谢魔杖
Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):433-435. doi: 10.4103/ijem.ijem_460_24. Epub 2024 Nov 8.
6
The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut-Brain Axis.胰高血糖素样肽-2 可能通过肠-脑轴参与调节摄食。
Nutrients. 2024 Sep 11;16(18):3069. doi: 10.3390/nu16183069.
7
The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis.β-连环蛋白在司美格鲁肽对去卵巢骨质疏松大鼠模型的骨保护作用中的关键作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2677-2693. doi: 10.1007/s00210-024-03378-z. Epub 2024 Sep 10.
8
Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases.预防或逆转慢性炎症性风湿性疾病中微生物群失调的当前方法。
Mediterr J Rheumatol. 2024 Jun 30;35(2):220-233. doi: 10.31138/mjr.240224.cap. eCollection 2024 Jun.
9
A network frame offers a promising transdisciplinary tool for understanding complex health and health care system problems like suicide.网络框架为理解复杂的健康和医疗保健系统问题(如自杀)提供了一种有前途的跨学科工具。
Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2402194121. doi: 10.1073/pnas.2402194121. Epub 2024 Aug 13.
10
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects.食欲调节中的新型药物:探索新兴的肠道肽及其药理学前景。
Pharmacol Res Perspect. 2024 Aug;12(4):e1243. doi: 10.1002/prp2.1243.
Tirzepatide Once Weekly for the Treatment of Obesity.
司美格鲁肽每周一次治疗肥胖症。
N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.
4
Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases.膳食多酚:调节晚期糖基化终产物-受体相互作用分子轴和微生物群-肠道-脑轴以预防神经退行性疾病。
Crit Rev Food Sci Nutr. 2023;63(29):9816-9842. doi: 10.1080/10408398.2022.2076064. Epub 2022 May 19.
5
Role of the gut-brain axis in energy and glucose metabolism.肠脑轴在能量和葡萄糖代谢中的作用。
Exp Mol Med. 2022 Apr;54(4):377-392. doi: 10.1038/s12276-021-00677-w. Epub 2022 Apr 26.
6
Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis.胰高血糖素样肽-1 受体激动剂对糖尿病患者自主神经功能的影响:系统评价和荟萃分析。
Diabetes Metab J. 2022 Nov;46(6):901-911. doi: 10.4093/dmj.2021.0314. Epub 2022 Apr 12.
7
Trends in the Prevalence of Obesity and Its Phenotypes Based on the Korea National Health and Nutrition Examination Survey from 2007 to 2017 in Korea.韩国 2007 年至 2017 年全国健康营养调查中肥胖及其表型的流行趋势。
Diabetes Metab J. 2022 Sep;46(5):808-812. doi: 10.4093/dmj.2021.0226. Epub 2022 Mar 8.
8
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.每周皮下司美格鲁肽与每日利拉鲁肽对无糖尿病超重或肥胖成年人体重的影响:STEP 8 随机临床试验。
JAMA. 2022 Jan 11;327(2):138-150. doi: 10.1001/jama.2021.23619.
9
Obesity, Diabetes, and Increased Cancer Progression.肥胖、糖尿病与癌症恶化。
Diabetes Metab J. 2021 Nov;45(6):799-812. doi: 10.4093/dmj.2021.0077. Epub 2021 Nov 22.
10
Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study.钠-葡萄糖共转运蛋白 2 抑制剂与胰高血糖素样肽-1 受体激动剂联合治疗 2 型糖尿病的临床疗效:真实世界研究。
Diabetes Metab J. 2022 Jul;46(4):658-662. doi: 10.4093/dmj.2021.0232. Epub 2021 Nov 8.